<?xml version="1.0" encoding="UTF-8"?>
<p>This product is the first FDA-approved prescription plant-derived, purified pharmaceutical-grade cannabidiol (CBD), which is administered orally to treat seizures associated with Lennox-Gastaut syndrome or Dravet syndrome [
 <xref rid="B175-molecules-25-04036" ref-type="bibr">175</xref>]. Epidiolex
 <sup>®</sup> contains no Δ9-THC.
</p>
